rfhg_13475.1

Basic information about the TSS

---

TSS ID: rfhg_13475.1 Species: human Chr: chr1		Start: 155135808 End: 155135814 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2225366,EH38E1386892)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000368401.6:0 ENST00000622581.4:0 AK289551:0 GeneID: 55974 HGNC/MGI_ID: HGNC:30657 UniProt_ID: A0A087WXX5 Q9BRV3 Nearer transcript ids and distances: ENST00000490276.5:14 ENST00000303343.12:36 AF126023:36 BC009621:36 ENST00000368404.9:38 NM_001287586.2:38 NM_001287589.2:38 NM_001122837.2:38 NM_001287588.2:38 NM_001122839.2:38 NM_018845.4:38 NM_001287587.2:38 ENST00000650403.1:44 AF126024:44 ENST00000368405.7:45 BC012378:49 ENST00000488609.5:53 BC005943:54 LF206179:-55 MA441756:-55 ENST00000506037.1:83 BC010869:83 BC069245:83 HQ447165:93 KJ894297:93 KJ899222:93 CR457148:98 CU679421:98 LF352217:217 MA587794:217 LF352216:390 MA587793:390 ENST00000465546.5:-415 ENST00000475824.6:-417 NM_001287592.2:-433 NM_001287591.2:-433 NM_001287590.2:-433 ENST00000490770.5:-451 ENST00000484157.5:-464 view more...

Gene_name: solute carrier family 50 member 1 Gene_symbol: SLC50A1 Gene_synonyms: HsSWEET1 RP11-540D14.5 RZPDo834D038D SCP SWEET1 slv Gene_source: HGNC:30657

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_001287586
Entrez ID:	55974
Nearest Unigene:	Hs.292154
Nearest Refseq:	NM_018845
Nearest Ensembl:	ENSG00000169241
Gene Name:	solute carrier family 50 member 1
Gene Alias:	HsSWEET1|RAG1AP1|SCP|SWEET1|slv
Gene Type:	protein-coding
CpG%:	0.166667
GC%:	0.714286
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SLC50A1 p2@SLC50A1 p3@SLC50A1 p4@SLC50A1 p6@SLC50A1 p7@SLC50A1
Sample		p1@SLC50A1	p2@SLC50A1	p3@SLC50A1	p4@SLC50A1	p6@SLC50A1	p7@SLC50A1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.97	0.58	1.17	0.19	0.39	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	15.78	0.40	1.01	0.40	0.61	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	18.13	0.19	0.96	0.39	0.96	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.89	0.62	1.04	0.00	1.66	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	14.17	0.45	1.12	0.67	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	17.83	0.78	1.16	0.00	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.48	2.18	1.74	0.44	1.31	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.71	0.97	1.94	0.00	1.21	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.38	1.50	0.64	0.43	1.28	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	23.19	5.80	1.16	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.62	4.04	2.43	0.81	2.43	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.80	5.29	0.41	0.00	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	21.92	1.93	0.64	0.16	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.40	0.60	0.60	0.15	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.66	1.32	0.00	0.00	1.10	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.35	1.01	0.50	0.25	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.69	0.44	0.87	0.00	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.83	0.42	0.42	0.00	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	2.13	0.53	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.61	1.50	0.30	0.30	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.58	0.67	0.40	0.00	0.67	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.71	1.55	0.52	0.17	0.69	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.93	0.90	1.16	0.00	0.78	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.26	0.49	0.73	0.49	0.73	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.32	2.06	0.00	0.26	0.77	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.99	1.27	0.63	0.32	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	1.65	0.55	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.75	0.94	0.94	0.00	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.81	1.78	0.65	0.32	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.81	0.72	1.63	0.72	0.54	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.42	1.47	0.21	0.21	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.78	0.98	1.56	0.59	0.39	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.74	1.90	0.63	0.21	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	18.31	1.81	0.99	0.33	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.63	1.12	0.93	0.75	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.63	1.53	0.00	0.00	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.69	1.43	0.20	0.20	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.13	0.60	0.20	0.20	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.53	1.35	1.62	0.81	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	15.12	0.72	0.48	0.00	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	14.12	0.24	0.24	0.71	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	17.13	1.02	0.29	0.29	0.59	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.61	0.42	0.84	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.48	0.35	0.87	0.35	0.70	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.67	0.60	0.40	0.20	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.82	1.16	1.40	0.00	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.83	0.96	1.20	0.00	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.08	0.60	0.30	0.30	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.84	1.20	0.96	0.72	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.94	0.40	1.62	0.00	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.76	0.61	0.61	0.00	1.43	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.68	1.78	0.44	0.67	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.07	0.35	1.77	0.00	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	0.66	0.66	0.00	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.91	1.68	1.68	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.48	2.30	1.84	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.50	2.59	0.97	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.09	2.25	0.32	0.96	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.83	2.51	0.94	0.63	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	0.71	0.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	1.68	0.56	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	4.78	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.53	3.40	0.34	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.92	2.60	0.00	0.00	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.94	3.55	0.35	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.00	4.88	0.49	1.46	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	39.17	8.93	0.50	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	37.53	6.57	0.94	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.42	7.29	1.32	0.66	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	46.09	7.11	3.40	0.62	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	47.08	10.70	1.83	0.31	2.14	0.92
Adipocyte - breast, donor1	11376-118A8	31.99	0.48	1.27	0.32	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	35.94	0.32	1.28	0.32	0.96	0.32
Adipocyte - omental, donor1	11473-119C6	36.39	0.38	1.91	0.38	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	35.13	0.00	2.24	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	27.80	0.33	0.67	0.33	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	28.71	0.64	1.28	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	36.28	3.30	0.00	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	36.58	0.45	3.61	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	28.67	0.00	0.17	0.35	0.17	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	53.39	1.76	1.56	0.98	0.98	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	33.20	3.09	2.06	0.26	0.51	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	58.82	2.79	1.95	1.39	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	49.38	2.35	1.18	0.59	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	47.46	0.88	1.61	0.56	1.45	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	48.41	1.29	1.29	0.65	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	33.59	1.07	0.53	0.00	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	45.63	1.11	2.23	0.00	2.78	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	80.27	0.83	2.91	1.25	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	47.47	1.76	1.51	0.25	1.26	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	45.16	0.33	1.96	0.65	0.65	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	53.89	0.91	1.52	0.61	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	57.90	1.33	0.00	0.00	1.99	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	129.45	3.59	0.72	1.08	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	53.91	1.20	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	38.86	1.08	1.62	0.18	1.08	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	0.00	0.00	3.35	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	35.75	0.21	0.41	0.62	1.44	0.82
Anulus Pulposus Cell, donor1	11248-116E6	51.95	2.29	0.69	0.11	1.14	0.34
Anulus Pulposus Cell, donor2	11463-119B5	39.92	1.22	0.73	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	3.15	1.35	0.45	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	3.47	0.43	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.72	4.48	1.20	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	3.79	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	18.48	3.30	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.32	2.92	0.97	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	20.39	3.88	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.22	2.38	1.19	0.00	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	3.39	0.00	0.00	1.88	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.95	5.81	1.45	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	24.71	3.13	1.15	0.00	0.82	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.06	3.47	0.30	0.15	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.75	2.14	1.07	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.76	2.46	0.76	0.38	0.57	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.85	2.94	0.80	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	2.93	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	20.90	2.49	0.83	0.33	1.16	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	2.40	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.76	2.57	0.86	0.17	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.27	1.94	0.97	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.01	4.17	1.14	0.00	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	3.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.80	3.42	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.52	2.35	1.50	0.21	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.81	3.87	0.77	0.00	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.18	2.35	1.41	0.00	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.33	2.25	0.96	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	2.14	0.71	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.87	2.34	1.75	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.57	2.71	0.90	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	21.38	5.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	23.90	4.58	1.02	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.88	3.31	1.27	0.51	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.71	1.91	1.27	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.58	3.02	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.26	1.69	1.48	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	21.75	2.90	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	1.89	0.94	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.06	3.39	1.53	0.17	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	6.34	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.59	2.79	0.86	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	22.86	4.81	1.20	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	8.02	1.46	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.91	4.14	2.07	0.46	1.15	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.56	3.56	1.02	0.25	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.12	4.34	0.83	0.21	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.34	4.59	1.84	0.31	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.69	7.17	0.48	0.96	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.96	3.55	1.77	0.22	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	7.63	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	3.32	1.11	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.33	2.91	1.32	0.00	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.53	3.63	1.45	0.00	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	38.07	2.70	0.61	0.61	2.33	0.25
Astrocyte - cerebellum, donor2	11580-120F5	31.84	2.91	0.34	0.34	1.03	0.51
Astrocyte - cerebellum, donor3	11661-122F5	20.76	1.26	0.63	0.21	1.47	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	13.25	1.39	0.00	0.00	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	19.25	1.78	0.65	0.16	1.13	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	16.56	2.09	0.00	0.15	0.89	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	36.24	10.67	0.69	0.46	0.92	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	33.45	7.77	0.50	0.75	1.00	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	28.79	9.10	0.68	0.46	1.02	0.57
Basophils, donor1	12241-129G9	36.35	2.62	2.88	0.52	0.52	0.78
Basophils, donor2	12242-129H1	25.26	5.05	1.44	1.08	0.72	0.36
Basophils, donor3	12243-129H2	26.02	2.79	1.03	0.59	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	95.94	0.00	1.08	0.43	1.08	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	120.70	1.37	0.46	1.37	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	52.72	0.00	0.00	0.63	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	60.31	0.62	0.62	0.21	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	95.34	0.00	1.38	0.46	0.46	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	71.62	0.18	0.54	0.36	1.08	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	21.13	6.49	0.00	0.62	1.34	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	53.33	13.04	0.00	0.93	2.10	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	61.08	8.63	0.64	1.28	3.84	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	29.87	6.20	6.76	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	20.60	4.45	2.60	0.19	1.48	0.37
CD14+ Monocytes, donor3	11381-118B4	32.49	3.73	5.05	0.44	1.76	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	30.29	0.28	3.40	0.00	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	25.02	0.76	1.14	0.38	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	25.31	0.00	1.64	0.99	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	9.97	1.88	3.47	0.14	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	9.05	0.60	1.51	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	10.19	1.18	2.61	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	10.38	3.18	2.85	0.17	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.83	3.31	1.93	0.00	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.16	6.20	2.23	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	11.36	2.74	5.68	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.15	3.74	3.56	0.00	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.19	4.57	5.22	0.00	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	5.38	3.75	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.14	8.45	2.64	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	4.44	4.44	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.18	1.04	3.57	0.15	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.38	0.40	1.00	0.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.37	3.12	1.87	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.75	3.43	4.58	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.14	2.94	1.81	0.45	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4.36	2.62	2.62	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.26	1.34	4.30	0.00	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.69	1.92	3.84	0.00	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.68	2.10	4.63	0.00	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.21	6.61	4.41	0.18	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.62	6.69	2.82	0.00	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	6.14	3.95	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	14.12	2.09	5.06	0.00	0.52	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	14.12	2.97	4.09	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.24	2.80	8.62	0.00	1.08	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.28	9.01	2.05	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.82	7.65	2.78	0.00	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.38	10.44	4.18	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	36.62	1.96	3.49	0.22	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	36.27	3.93	4.16	0.69	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	34.44	1.73	2.38	0.43	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	30.83	1.71	3.89	0.78	0.93	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	27.42	1.92	5.76	0.87	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	25.20	0.67	3.57	0.22	0.89	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	34.70	0.77	2.81	0.26	1.02	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	33.37	0.88	2.20	0.00	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	45.27	1.05	2.11	0.21	1.47	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	85.36	2.03	0.00	0.00	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	76.61	2.71	1.36	0.68	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	92.17	4.14	1.04	0.00	0.00	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	77.82	2.13	0.00	0.53	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	105.07	2.68	0.00	2.14	2.68	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	96.87	2.11	0.00	1.40	2.81	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	114.52	3.92	1.57	0.00	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	116.01	0.00	0.00	3.95	7.91	1.32
CD19+ B Cells, donor1	11544-120B5	69.04	10.68	0.00	0.82	0.82	2.47
CD19+ B Cells, donor2	11624-122B4	55.13	21.04	0.00	0.00	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	52.50	16.66	0.00	0.00	2.52	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	79.20	0.00	0.00	1.62	1.62	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	63.52	0.40	0.00	1.20	3.20	0.40
CD34+ Progenitors, donor1	11545-120B6	33.13	10.04	0.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	33.71	24.16	1.69	1.69	1.69	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	37.58	6.01	0.75	1.13	3.76	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	46.22	4.96	1.13	1.35	5.41	0.68
CD4+ T Cells, donor1	11225-116C1	30.35	0.71	0.00	0.36	1.43	0.36
CD4+ T Cells, donor2	11306-117C1	33.07	2.45	0.61	0.00	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	25.92	0.91	0.00	0.00	0.91	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	55.90	0.77	0.26	1.53	2.81	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	67.60	0.45	0.22	0.67	3.59	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	59.79	1.72	0.00	1.15	1.44	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	42.19	0.00	0.00	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	35.12	0.70	0.00	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	41.48	0.43	0.00	0.58	1.45	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	54.06	0.51	0.17	1.02	2.54	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	55.29	0.97	0.00	1.77	2.26	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	34.52	0.45	0.00	0.00	0.45	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	24.81	0.00	0.00	0.00	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.92	0.00	0.00	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	46.80	1.26	0.42	0.84	2.11	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.67	0.42	0.42	0.42	1.66	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.44	0.33	0.33	1.00	4.01	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	32.36	0.00	0.00	0.82	1.63	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	41.27	0.00	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	0.00	0.00	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	45.99	0.37	0.19	1.48	4.82	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.31	0.22	0.22	0.87	3.47	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	38.04	0.21	0.00	0.42	2.73	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.38	0.00	0.00	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.03	0.43	0.00	0.00	1.73	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	26.58	0.44	0.00	0.44	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	55.43	0.99	0.00	1.48	0.99	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	37.85	0.00	0.00	0.00	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	34.90	0.00	0.00	0.00	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	44.31	1.38	0.55	0.55	1.66	3.05
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	45.40	0.49	0.00	0.49	1.47	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	40.04	0.00	0.00	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	48.70	0.72	0.00	0.36	0.36	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	1.38	0.00	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	31.10	0.98	0.00	0.33	0.65	0.65
CD8+ T Cells, donor2	11307-117C2	20.27	3.00	0.38	0.38	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	26.26	1.77	0.00	0.50	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	30.51	25.00	1.15	0.46	1.61	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	27.08	22.05	0.96	0.00	1.20	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.46	25.44	0.82	0.00	1.09	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	26.42	42.93	1.20	0.60	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.56	24.24	1.44	0.24	1.20	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	29.56	22.51	0.91	0.00	0.91	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	33.03	24.12	2.17	0.65	1.52	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	35.27	23.95	0.79	0.53	1.58	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	39.16	26.27	2.11	0.23	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	54.94	30.49	2.72	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	41.83	28.18	1.74	0.29	2.61	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	47.69	24.78	2.40	0.27	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.83	32.39	1.75	0.00	1.75	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	38.26	23.68	1.82	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	38.04	35.06	1.49	0.75	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	29.89	28.81	0.72	0.00	1.80	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.66	23.59	1.73	0.29	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.27	20.03	0.47	0.24	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	40.25	25.04	0.32	0.32	1.90	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	36.60	25.53	2.15	0.62	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	27.25	21.16	0.96	0.96	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	47.43	32.13	1.91	0.38	2.68	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	46.90	25.62	1.58	0.00	2.36	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	37.06	34.04	1.51	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.92	23.29	0.80	0.80	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	37.07	19.58	2.10	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	42.07	34.06	0.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	34.73	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	44.96	6.92	3.95	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	34.83	1.16	1.26	0.63	0.84	0.63
Chondrocyte - de diff, donor1	11261-116G1	38.13	1.04	1.04	0.35	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	30.21	0.71	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	24.69	0.68	1.37	0.23	0.46	0.23
Chondrocyte - re diff, donor2	11339-117F7	30.44	0.00	2.69	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	25.48	0.40	1.21	1.21	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	36.84	2.87	1.26	0.23	1.03	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	30.78	4.28	0.00	0.43	1.50	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	28.41	2.30	1.50	0.18	0.97	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	25.22	0.46	1.38	0.73	1.19	0.73
Corneal Epithelial Cells, donor1	11526-119I5	112.20	0.00	1.54	0.88	1.76	0.44
Corneal Epithelial Cells, donor2	11606-120I4	73.94	0.00	1.14	2.28	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	70.81	0.77	1.28	0.77	0.26	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	51.67	0.00	6.93	0.17	0.83	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	61.82	0.32	6.62	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	62.11	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	47.62	0.97	5.62	0.32	0.76	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	31.77	1.37	0.34	0.34	2.39	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	31.34	1.31	1.31	1.96	3.92	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	33.88	1.45	0.00	0.97	0.97	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	13.01	6.00	0.33	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	15.84	8.21	0.00	0.00	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	20.08	4.52	1.13	0.57	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	3.93	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	18.91	9.31	0.00	0.58	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	20.00	8.94	1.18	0.47	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	13.67	6.66	0.70	0.18	0.35	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.96	3.77	0.66	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.99	3.65	0.30	0.30	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	17.76	4.51	0.28	0.28	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	32.68	14.56	0.00	0.00	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	24.47	28.64	1.04	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	16.73	10.63	0.43	0.00	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	30.81	10.00	0.00	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	9.96	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	35.29	11.80	1.74	0.00	0.75	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.94	12.38	0.43	0.00	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.75	10.38	0.85	0.12	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	17.06	9.10	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	11.18	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.17	7.38	0.47	0.00	0.31	0.16
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	37.96	1.65	4.95	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	80.87	0.00	1.22	0.49	1.22	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	137.29	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.09	0.00	1.23	0.41	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	43.25	1.42	0.88	0.33	1.31	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.63	1.41	1.30	0.00	0.43	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	33.96	1.46	0.85	0.12	0.97	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.52	0.27	1.09	0.27	0.27	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.11	1.27	0.53	0.11	0.32	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.46	1.05	1.32	0.26	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.25	1.66	1.00	0.66	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	27.22	1.81	1.36	0.00	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	25.77	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	27.76	0.95	0.79	0.63	0.95	1.10
Fibroblast - Cardiac, donor4	11452-119A3	29.10	0.91	1.21	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	34.26	5.58	0.63	0.13	0.63	0.25
Fibroblast - Cardiac, donor6	11460-119B2	29.56	2.43	1.06	0.00	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	46.90	2.55	0.40	0.27	1.21	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	16.39	2.16	0.86	0.00	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	4.39	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	80.72	3.92	0.00	0.23	2.54	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	21.71	1.87	0.34	0.34	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	24.42	0.70	0.23	0.00	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	31.13	5.66	1.42	0.00	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	25.87	0.73	0.36	0.12	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	34.14	2.37	0.34	0.34	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	31.05	1.92	0.17	0.00	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	33.62	2.92	0.16	0.32	0.97	0.49
Fibroblast - Gingival, donor1	11237-116D4	49.14	2.29	0.62	0.00	1.04	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.89	0.26	1.57	1.05	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	37.82	2.24	0.66	0.66	1.05	0.40
Fibroblast - Gingival, donor3	11394-118C8	51.53	1.35	0.29	0.10	0.39	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	2.08	3.12	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.21	0.18	0.53	0.35	0.18	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.15	1.40	0.31	0.31	1.09	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	22.45	1.08	0.68	0.81	0.54	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.59	0.71	0.35	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	26.62	0.58	1.17	0.15	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.18	0.95	0.95	0.41	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	16.67	1.54	0.44	0.22	0.66	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	17.76	1.17	0.59	0.15	0.59	0.44
Fibroblast - Lung, donor1	11270-116H1	16.31	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	25.32	0.42	0.63	0.63	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	97.46	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	47.55	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	58.77	1.68	0.28	0.00	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	48.31	1.22	0.00	0.81	1.22	0.41
Fibroblast - Mammary, donor2	11620-122A9	75.89	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.38	2.13	0.19	0.19	0.78	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	29.88	2.88	0.61	0.30	0.30	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.33	0.92	1.53	0.00	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.86	0.76	1.53	0.38	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.57	0.81	0.54	0.81	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.60	0.35	0.81	0.12	0.70	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.44	1.22	1.11	0.22	0.88	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	64.82	1.22	1.22	0.41	1.42	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	6.01	0.00	0.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.07	3.95	0.79	0.00	0.40	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.33	0.40	0.60	0.20	0.60	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.16	0.18	0.18	0.53	0.71	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.00	0.59	0.39	0.20	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.96	0.30	2.41	0.30	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.15	0.65	1.08	0.11	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.92	0.00	0.25	0.51	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	29.21	0.16	0.82	0.33	1.15	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	25.06	0.20	1.00	0.60	0.80	1.00
Fibroblast - skin normal, donor2	11561-120D4	29.74	0.60	0.30	0.20	1.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	11.18	0.30	0.91	0.30	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	20.88	0.75	0.75	0.08	0.99	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.52	1.71	1.20	0.17	1.54	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	0.00	0.66	0.99	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.80	1.17	0.21	0.32	0.75	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	25.30	1.01	1.01	0.34	1.52	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	19.13	0.78	1.57	0.31	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	0.00	0.00	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.62	0.35	0.17	0.52	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.64	0.78	0.52	0.26	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.41	1.02	0.00	0.00	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	7.66	0.00	0.77	3.06	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	43.39	12.12	0.00	0.00	2.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	52.49	7.42	0.29	1.14	2.57	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	44.12	2.76	0.00	0.00	0.83	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	20.32	1.83	0.00	0.00	0.91	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.15	4.16	0.00	0.59	0.79	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	42.56	4.49	0.26	0.26	1.06	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	20.22	0.65	0.00	0.00	2.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	57.49	5.31	0.00	0.44	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	38.72	6.08	0.14	0.85	1.98	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	26.35	2.34	0.12	0.00	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.88	5.37	0.27	0.54	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.42	4.21	0.50	0.37	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.18	4.71	0.14	0.28	1.11	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.89	5.90	0.20	0.20	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	27.15	1.83	1.14	0.23	0.46	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.18	2.87	0.62	0.25	1.12	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	24.70	2.19	1.09	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.07	3.55	0.59	0.30	2.36	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.75	3.34	0.32	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.66	2.68	0.00	1.12	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.14	5.85	0.20	0.20	2.02	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	17.13	3.56	0.34	0.00	0.85	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.30	3.81	0.62	0.27	0.98	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.72	3.33	0.31	0.42	0.94	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.76	2.73	0.00	0.51	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	20.14	3.76	0.22	0.22	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.88	2.41	0.50	0.33	0.83	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.77	2.45	0.41	0.61	1.63	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.28	5.57	0.21	0.41	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.21	3.69	0.23	0.12	1.61	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.34	3.67	0.50	0.33	0.83	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.26	4.85	0.44	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.84	2.34	0.25	0.00	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.91	2.43	0.32	0.16	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.66	4.17	0.96	0.00	0.64	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.98	2.27	0.19	0.00	0.47	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.40	2.85	0.00	0.47	0.79	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.20	4.26	0.91	0.00	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.67	2.20	0.52	0.10	0.52	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.86	2.20	0.44	0.44	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.11	2.24	0.56	0.28	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.24	1.20	0.28	0.09	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.12	4.01	0.53	0.00	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.54	2.14	0.77	0.31	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.32	2.20	0.39	0.26	1.04	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	23.85	1.36	0.54	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.25	2.21	0.74	0.37	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.45	3.73	0.44	0.44	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	0.99	0.99	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.81	2.64	0.26	0.13	0.66	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.45	3.63	0.40	0.61	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	36.85	0.51	0.51	0.00	1.78	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	32.05	6.37	0.20	0.60	1.19	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	26.50	3.70	0.00	0.92	1.54	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	34.98	6.75	0.00	0.82	2.66	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.26	7.20	0.00	0.63	2.50	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	52.84	6.22	0.00	0.85	4.80	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	39.20	4.15	0.00	0.00	2.31	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	9.90	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	34.81	6.19	1.16	0.00	2.32	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	9.63	0.00	0.00	4.81	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	38.41	8.14	0.98	0.00	2.28	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.77	2.47	1.24	0.00	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	3.33	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	41.95	6.15	0.56	0.84	2.24	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	36.93	6.21	0.33	0.33	1.63	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.10	4.19	1.68	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	48.03	6.04	0.64	0.95	1.91	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	52.31	8.15	0.68	0.68	3.40	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	14.62	2.09	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	50.97	12.03	0.57	0.00	2.86	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	60.97	8.58	0.00	0.59	1.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	5.08	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.85	8.70	1.66	1.66	1.66	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	42.80	9.21	0.92	1.15	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	10.54	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	41.13	10.76	0.00	1.15	3.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	51.83	7.50	0.33	0.65	2.61	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	68.89	20.07	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	57.40	12.33	0.39	0.00	1.93	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	35.60	7.19	0.34	1.03	1.71	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	64.64	12.74	0.00	0.47	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.97	11.47	0.60	0.00	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.39	13.23	0.51	0.00	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	67.80	13.16	0.40	0.40	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	60.19	15.79	0.00	0.99	2.96	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	16.53	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	59.51	14.00	0.00	0.00	0.58	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	80.32	13.17	1.32	0.00	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	5.09	0.00	0.85	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	10.15	0.60	0.60	3.58	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	38.33	10.19	0.97	1.46	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	1.14	0.00	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	23.70	2.08	0.42	0.00	0.83	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	14.59	0.32	2.54	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	24.65	0.42	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	71.37	1.39	2.32	0.93	3.13	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	72.08	2.03	3.54	0.51	0.84	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	69.84	2.73	1.37	0.23	1.59	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	77.28	1.53	2.51	1.09	2.73	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	74.36	0.86	2.15	0.43	2.36	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	63.51	1.51	1.08	1.08	3.01	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	78.83	2.24	3.86	0.62	1.49	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	76.17	2.06	2.74	0.69	2.92	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	65.68	0.32	3.20	0.00	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.94	12.31	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.03	6.49	0.43	0.43	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	5.29	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	67.02	2.82	1.41	0.00	1.76	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	54.49	4.36	4.36	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.96	6.29	2.45	0.00	0.70	1.40
Hepatocyte, donor1	11523-119I2	29.05	1.21	2.42	0.00	1.21	2.42
Hepatocyte, donor2	11603-120I1	44.17	0.00	6.46	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	25.16	0.00	1.84	1.23	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	21.54	0.00	0.00	0.00	1.96	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	96.13	0.35	1.40	1.92	6.29	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.24	2.47	0.69	0.27	0.82	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	79.60	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	86.78	0.00	6.68	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	85.83	1.38	5.54	2.77	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	77.58	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	82.01	2.56	5.13	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	0.00	0.00	4.57	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	86.09	0.00	4.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	66.69	3.33	1.67	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	0.00	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	60.88	1.32	2.65	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	64.30	0.00	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	0.00	0.00	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	66.77	0.63	0.63	1.26	1.89	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	68.05	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	55.56	1.94	3.23	0.00	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	94.99	0.00	3.22	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.08	1.63	0.00	0.81	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	95.72	1.26	5.04	0.00	1.26	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	81.17	2.41	2.41	0.00	3.21	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	72.94	0.00	2.77	0.92	2.77	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	72.22	0.00	5.66	0.47	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	53.51	0.91	2.72	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	101.16	0.00	4.30	1.08	3.23	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	94.01	0.00	2.54	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	88.64	0.64	3.83	1.91	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	72.91	0.00	1.82	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	77.83	0.00	2.14	0.00	0.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	0.00	3.32	0.00	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	67.91	1.23	3.09	0.62	2.16	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	82.53	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	75.44	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.72	0.00	2.78	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	108.44	0.00	0.00	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	3.24	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	61.91	0.00	1.74	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	60.74	0.00	0.00	0.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	0.00	6.97	0.00	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	80.01	1.07	5.33	1.07	7.47	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	55.23	0.00	2.76	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	84.71	0.00	0.00	0.00	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	95.16	2.11	5.29	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	42.68	0.33	0.16	0.08	0.65	0.16
Keratinocyte - epidermal, donor2	11349-117G8	55.64	0.59	1.17	0.00	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	46.57	0.38	1.42	0.57	0.95	0.19
Keratinocyte - oral, donor1	11251-116E9	80.03	0.34	0.34	0.68	1.25	1.02
Keratocytes, donor1	11527-119I6	70.14	5.16	0.69	0.69	3.09	0.34
Keratocytes, donor2	11607-120I5	62.11	4.69	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	20.55	3.16	0.20	0.40	0.59	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	29.13	3.24	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.14	2.19	0.23	0.46	1.15	0.81
Lens Epithelial Cells, donor3	11690-122I7	33.00	1.11	0.40	0.40	0.50	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.71	16.84	0.59	0.00	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	26.51	14.51	1.95	0.00	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.14	14.32	1.73	0.16	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.04	15.06	1.08	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	24.58	16.39	0.32	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	23.40	14.77	1.29	0.22	0.43	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	23.39	15.59	2.05	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.32	19.97	1.77	0.51	1.01	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.27	14.78	1.69	0.14	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	21.36	18.99	0.79	0.40	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.98	16.09	0.58	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.88	14.63	1.48	0.00	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.78	21.95	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.67	15.50	0.72	0.24	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.68	16.76	1.37	0.00	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.72	12.01	1.23	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.50	15.28	0.94	0.31	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.10	15.92	1.65	0.18	1.28	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.94	18.10	0.66	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.36	21.38	0.29	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.39	16.68	1.49	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.34	17.46	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.93	20.20	0.81	0.27	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	23.61	18.17	0.91	0.45	0.45	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	14.00	0.52	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.52	16.54	1.47	0.00	0.21	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.51	14.74	1.05	0.15	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	19.26	1.38	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.40	15.43	0.94	0.19	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	24.28	15.16	1.38	0.21	0.32	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	14.05	0.97	0.00	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.49	12.90	1.32	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.53	15.98	1.36	0.25	0.87	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	26.28	19.99	1.85	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.50	19.52	0.25	0.25	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.02	14.44	1.37	0.14	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	30.23	12.87	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	30.43	18.87	0.61	0.00	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	23.93	12.04	1.26	0.14	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.96	15.64	0.71	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.69	17.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	24.43	15.09	2.02	0.00	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.20	11.10	1.79	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.48	15.68	0.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	28.72	15.77	2.12	0.47	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.49	15.96	1.11	0.12	0.74	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.08	14.60	0.77	0.00	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.57	18.50	0.90	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	86.11	2.27	0.00	0.00	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	72.11	0.00	2.30	2.30	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	65.32	1.48	0.74	0.74	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	68.55	0.00	1.27	0.42	3.39	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	77.37	0.70	2.11	0.00	5.63	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	62.58	0.00	2.80	0.93	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	62.35	0.52	2.06	0.00	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	86.83	0.00	0.00	0.00	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	86.86	0.00	1.81	2.49	3.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	69.22	0.58	1.16	1.16	2.04	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	64.83	0.45	0.90	0.45	2.25	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	84.81	1.08	1.90	1.08	3.66	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	70.87	2.05	0.51	1.03	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	69.16	0.71	1.41	1.41	2.12	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	73.29	0.67	4.66	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	69.28	0.51	2.04	2.04	3.57	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	65.90	0.53	0.27	1.07	2.67	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	74.63	0.94	1.32	0.57	2.83	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	85.90	0.00	2.45	1.84	3.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	70.94	1.63	1.63	1.63	3.26	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	73.51	1.04	1.67	0.83	2.50	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	66.42	0.28	1.12	0.84	2.52	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	73.15	1.03	3.09	3.09	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	64.45	0.58	2.61	0.58	2.32	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	77.42	0.30	1.49	0.60	2.39	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	66.39	1.66	2.77	2.21	2.77	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	66.81	1.06	1.06	0.35	2.47	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	68.22	0.37	1.48	1.11	3.32	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	65.62	1.15	1.15	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	73.30	0.77	1.15	0.00	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	57.75	1.13	0.57	0.57	2.26	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	73.02	0.82	0.82	3.28	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	71.85	1.36	1.81	0.90	2.26	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	78.28	0.72	3.59	1.44	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	72.45	0.00	3.73	0.75	3.73	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	63.54	1.86	2.23	1.11	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	71.50	0.86	1.29	2.15	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	71.93	0.86	0.86	0.00	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	71.97	0.33	1.33	1.00	3.66	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	78.43	2.41	1.21	1.81	4.83	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	62.57	0.00	1.42	1.42	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	76.31	0.34	3.09	1.03	2.75	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	72.46	1.61	2.15	0.54	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	82.82	0.00	0.67	0.67	2.02	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	69.64	1.48	1.11	1.11	3.70	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	81.41	0.00	1.16	2.33	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	77.22	1.06	1.06	0.00	3.17	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	76.43	0.00	2.40	1.20	3.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	82.14	1.45	1.45	2.18	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	81.25	0.00	2.30	0.77	6.13	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	85.34	0.99	1.97	0.00	4.93	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	82.80	0.94	0.94	1.88	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	93.52	0.00	4.02	0.50	2.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	69.40	0.45	0.90	0.00	2.70	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	72.29	1.72	5.16	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	85.06	0.89	2.67	0.45	3.56	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	70.78	0.78	1.96	0.39	2.35	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	69.27	0.66	3.30	1.98	2.64	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	88.22	0.52	2.08	0.52	3.63	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	82.26	1.31	2.19	0.44	5.25	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	74.92	0.56	2.80	2.24	2.24	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	73.31	1.77	1.32	2.21	4.86	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	83.31	0.77	2.70	0.77	2.70	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	73.93	1.01	1.52	1.52	3.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	69.21	0.96	2.88	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	74.34	1.19	2.78	0.40	1.59	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	74.13	0.00	1.22	1.82	3.65	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	60.87	1.38	0.69	0.69	3.46	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	58.90	1.90	1.14	0.38	3.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	73.85	1.03	0.52	0.52	3.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	87.07	0.60	0.00	0.60	1.81	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	75.74	1.27	2.54	0.63	2.85	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	81.03	0.00	0.53	1.07	4.80	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	81.60	0.57	0.57	1.72	2.30	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	86.39	0.00	2.57	0.51	4.11	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	85.59	0.00	1.41	0.00	2.12	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	87.96	0.57	0.00	0.57	4.54	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	68.23	2.08	0.83	2.08	2.08	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	86.92	0.78	0.78	0.00	3.13	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	85.60	0.84	1.25	1.67	3.76	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	72.95	1.39	1.86	0.00	4.65	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	86.31	1.34	0.67	1.34	6.69	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	85.54	0.00	0.53	0.53	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	80.01	0.81	2.83	1.21	4.04	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	89.02	3.67	0.92	0.92	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	101.36	0.89	0.89	0.89	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	94.60	0.57	2.85	1.14	3.42	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	93.56	0.77	1.53	3.07	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	84.27	0.55	0.55	1.09	4.92	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	85.53	1.34	1.78	0.89	3.12	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	101.12	0.78	2.08	1.30	2.86	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	89.52	2.65	1.33	0.66	2.65	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	91.46	0.00	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	27.81	0.23	4.56	0.23	0.23	0.91
Macrophage - monocyte derived, donor2	11313-117C8	40.00	0.73	2.02	0.00	0.37	0.55
Macrophage - monocyte derived, donor3	11389-118C3	35.79	0.52	2.23	0.13	1.05	1.44
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.33	1.06	1.06	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	29.63	0.48	0.32	0.32	0.63	0.32
Mallassez-derived cells, donor3	11930-125I4	37.39	0.56	0.56	0.28	0.56	0.42
Mammary Epithelial Cell, donor1	11273-116H4	65.57	0.00	2.19	1.10	0.60	0.80
Mammary Epithelial Cell, donor2	11350-117G9	55.59	0.29	0.58	0.00	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	17.46	0.00	0.75	0.25	0.75	0.50
Mast cell - stimulated, donor1	11487-119E2	31.86	20.34	7.46	1.36	1.36	0.00
Mast cell, donor1	11563-120D6	30.50	3.78	2.38	0.87	1.51	0.32
Mast cell, donor2	11565-120D8	34.77	8.32	3.57	0.59	0.00	1.19
Mast cell, donor3	11566-120D9	37.60	14.86	4.28	0.23	0.23	2.48
Mast cell, donor4	11567-120E1	36.17	5.14	2.30	0.71	0.18	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	32.94	2.00	4.77	0.78	1.00	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	36.77	1.75	2.92	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	26.96	1.61	1.84	0.46	1.26	0.34
Mast cell, expanded, donor8	11941-126A6	28.79	3.01	1.84	0.33	1.51	0.17
Melanocyte - dark, donor1	11502-119F8	57.81	19.80	0.99	0.30	0.80	0.30
Melanocyte - dark, donor2	11582-120F7	48.11	7.27	2.77	0.35	0.00	1.04
Melanocyte - dark, donor3	11663-122F7	40.78	0.80	0.65	0.58	0.94	0.51
Melanocyte - light, donor1	11274-116H5	36.44	0.47	0.47	0.24	1.18	0.47
Melanocyte - light, donor2	11351-117H1	44.36	0.68	0.00	0.00	1.36	0.68
Melanocyte - light, donor3	11423-118G1	23.42	1.73	0.87	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	36.24	1.15	0.94	0.21	1.15	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	38.46	0.54	0.54	0.00	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	62.14	1.87	0.80	0.80	2.14	1.07
Meningeal Cells, donor1	11493-119E8	30.02	3.97	0.50	0.12	1.36	0.25
Meningeal Cells, donor2	11573-120E7	25.97	3.52	0.00	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	17.69	2.20	0.49	0.08	1.30	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	37.93	4.56	0.86	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.43	0.70	0.91	0.40	0.40	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	89.36	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	70.64	0.00	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.86	3.59	0.72	0.00	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.07	0.42	0.64	0.21	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	26.14	0.50	0.00	0.00	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	54.06	2.86	0.66	0.22	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	35.80	2.19	0.73	0.00	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	38.06	1.84	1.23	0.41	1.02	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	39.20	0.97	0.55	0.69	1.25	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	60.59	1.86	1.12	0.37	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.29	1.32	0.79	0.39	0.53	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	37.98	0.89	0.00	0.00	0.59	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	60.20	3.20	3.84	0.64	1.28	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	43.60	1.77	2.13	0.00	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	30.02	0.63	0.63	0.63	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	39.91	4.35	2.18	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	41.37	0.53	0.80	0.27	1.06	0.53
Mesothelial Cells, donor2	12156-128G5	39.04	0.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	25.29	0.36	1.59	0.58	0.36	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	1.35	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.17	1.97	2.96	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.09	0.29	1.77	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.94	0.31	1.86	0.00	0.93	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.44	0.62	1.87	0.00	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	37.29	1.25	3.75	0.25	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.34	0.47	1.86	0.00	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.65	2.03	3.25	0.20	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	21.38	0.40	2.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	4.42	1.77	0.00	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	1.14	1.14	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	3.95	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	37.56	2.33	3.82	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.44	2.09	2.38	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	31.61	4.52	3.51	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.59	0.95	0.95	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	1.66	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	26.94	3.45	4.84	0.23	0.92	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.46	0.63	2.52	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.24	6.11	2.24	0.41	0.20	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.39	1.93	2.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.56	0.67	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	24.31	2.63	1.53	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	0.51	2.53	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.93	2.45	3.53	0.27	0.54	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.88	0.59	0.88	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.03	5.77	3.36	0.00	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.01	0.40	1.60	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	0.00	4.11	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	25.03	4.51	4.00	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	23.65	5.69	4.38	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	2.21	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.17	1.28	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.57	6.20	4.96	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	5.81	3.76	0.00	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.25	0.88	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.33	3.20	0.71	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	33.39	10.10	4.21	0.28	1.40	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.63	0.83	2.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	2.33	0.58	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.64	3.92	2.11	0.00	1.51	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.70	1.67	0.42	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	9.24	5.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	28.46	3.98	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.85	8.01	2.49	0.14	0.28	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.02	8.81	3.37	0.00	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	27.03	3.00	3.00	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	23.50	4.45	1.27	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.16	9.07	2.14	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	38.61	1.50	3.59	0.30	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.05	6.07	1.84	0.28	0.85	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	48.41	14.33	3.82	0.32	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.25	5.53	3.32	0.22	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	22.75	4.93	2.65	0.38	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	40.34	9.66	7.39	0.28	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	47.19	3.44	3.44	0.25	0.25	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	30.63	3.91	2.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	46.46	10.29	3.53	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	45.27	4.04	4.90	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	56.88	3.71	1.65	0.41	1.24	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.50	5.96	4.17	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	59.14	0.99	2.30	0.33	1.64	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	2.10	3.16	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	38.35	0.79	2.57	0.20	0.40	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	41.68	1.13	1.13	0.38	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	52.20	0.53	2.66	0.27	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	28.05	0.90	1.02	0.34	0.79	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	37.57	0.00	2.21	0.74	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	47.64	2.56	2.20	0.37	1.47	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	38.89	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	42.22	4.81	2.67	0.53	1.60	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	51.51	2.02	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	38.37	1.69	1.26	0.00	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	69.46	4.09	1.36	1.36	4.09	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	76.30	3.81	1.91	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	97.18	5.67	4.05	0.81	3.24	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	63.44	6.04	4.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	5.71	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	9.79	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	9.50	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.24	1.72	0.22	0.22	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	32.40	0.00	0.52	0.52	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	0.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	0.42	0.00	0.00	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.12	2.09	0.57	0.38	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	15.64	0.00	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	1.67	0.00	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.10	0.93	0.46	0.00	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.27	1.62	0.27	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.60	0.63	0.00	0.42	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.35	0.99	0.50	0.00	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.05	1.62	0.27	0.27	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.79	2.27	0.45	0.68	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.00	0.65	0.16	0.33	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.77	1.46	0.36	0.18	0.91	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	1.06	0.53	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.21	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.88	4.27	0.98	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.60	1.14	0.00	0.00	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	17.46	1.41	0.88	0.71	0.71	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	0.70	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.63	0.00	0.46	0.00	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	0.64	0.32	0.96	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.21	1.03	1.72	0.00	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.93	1.11	1.56	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	0.00	0.00	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.82	1.19	1.19	0.47	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.33	0.43	0.86	0.00	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.99	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	1.80	0.45	0.00	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.89	1.19	1.59	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.30	1.89	0.76	0.38	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.20	0.65	0.33	0.98	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	0.00	0.00	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	15.38	0.45	0.00	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	1.33	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.84	1.49	1.49	1.98	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.29	0.00	0.77	0.00	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.99	0.60	1.21	0.30	0.00	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.25	0.44	0.22	0.44	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	1.36	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	0.61	1.22	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.25	0.31	0.31	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	0.61	0.00	0.91	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	0.79	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	1.13	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	29.57	0.37	0.87	0.12	0.37	0.75
Myoblast, donor2	11322-117D8	26.85	0.19	0.77	0.00	0.19	0.00
Myoblast, donor3	11398-118D3	19.84	0.67	0.00	0.17	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	50.05	2.04	0.00	2.19	2.33	0.73
Natural Killer Cells, donor1	11230-116C6	28.91	2.46	0.62	0.31	1.54	0.92
Natural Killer Cells, donor2	11311-117C6	22.32	4.52	0.60	0.60	0.90	0.60
Natural Killer Cells, donor3	11387-118C1	31.29	7.55	0.74	0.00	1.10	0.18
Neural stem cells, donor1	11275-116H6	8.71	1.45	0.00	0.00	1.09	0.00
Neural stem cells, donor2	11352-117H2	13.48	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	7.97	2.28	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	11.89	0.44	0.22	0.00	0.22	0.44
Neurons, donor3	11655-122E8	9.87	0.82	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	13.92	2.78	1.86	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	15.27	0.61	2.44	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	28.14	1.31	0.12	0.12	0.71	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	41.35	2.60	0.33	0.00	0.65	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	40.11	2.81	0.00	0.00	0.40	1.40
Olfactory epithelial cells, donor1	11933-125I7	16.52	1.10	0.83	0.14	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	24.61	1.88	0.87	0.43	0.43	0.29
Olfactory epithelial cells, donor3	11935-125I9	25.43	0.68	0.23	0.45	0.57	0.23
Olfactory epithelial cells, donor4	11936-126A1	21.52	0.49	1.56	0.29	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	79.44	1.20	2.41	0.00	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	24.89	0.43	0.21	0.00	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	26.29	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	24.83	1.24	0.62	1.24	0.00	1.24
Osteoblast, donor1	11277-116H8	46.90	4.50	0.78	0.78	0.59	0.20
Osteoblast, donor2	11354-117H4	23.18	2.81	0.00	0.70	2.11	0.00
Osteoblast, donor3	11426-118G4	27.02	0.71	0.71	0.18	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	29.23	1.94	0.93	0.25	0.93	0.76
Pericytes, donor1	11491-119E6	45.29	2.34	0.33	0.33	1.22	1.22
Pericytes, donor2	11571-120E5	22.18	2.04	0.23	0.68	0.91	1.36
Pericytes, donor3	11652-122E5	43.54	3.87	1.02	0.41	0.61	1.42
Perineurial Cells, donor1	11499-119F5	27.46	1.13	0.57	0.68	0.23	0.68
Perineurial Cells, donor2	11579-120F4	47.20	4.69	3.22	0.09	1.84	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	28.05	0.96	0.64	0.00	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.81	3.43	2.20	0.00	1.71	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	23.94	1.29	1.42	0.39	0.52	0.65
Placental Epithelial Cells, donor1	11278-116H9	47.35	0.48	7.89	1.43	3.35	0.00
Placental Epithelial Cells, donor2	11355-117H5	77.62	3.33	2.22	0.00	3.33	2.22
Placental Epithelial Cells, donor3	11427-118G5	47.51	2.16	3.53	0.59	1.96	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	35.44	0.32	1.58	0.00	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	29.08	0.00	0.00	0.38	0.19	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.44	0.00	0.91	0.26	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	23.42	0.23	0.68	0.00	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	33.67	0.32	0.85	0.53	0.96	0.64
Preadipocyte - omental, donor2	11329-117E6	25.32	0.00	1.75	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	25.93	0.14	1.58	0.29	0.57	0.14
Preadipocyte - perirenal, donor1	11469-119C2	45.28	0.00	0.98	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	44.22	1.23	2.76	0.00	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	36.65	2.30	1.24	0.35	0.53	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	40.53	1.87	0.85	0.51	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	37.63	0.65	1.12	0.19	0.84	0.28
Preadipocyte - visceral, donor2	11357-117H7	51.54	1.84	1.84	0.00	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	33.85	0.84	1.04	0.31	0.42	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.52	1.06	0.75	0.75	3.62	0.30
Prostate Epithelial Cells, donor2	11331-117E8	21.80	0.14	0.14	0.27	0.27	0.41
Prostate Epithelial Cells, donor3	11404-118D9	86.28	0.18	2.82	0.61	0.73	1.10
Prostate Stromal Cells, donor1	11254-116F3	30.98	0.46	1.37	0.57	0.23	0.34
Prostate Stromal Cells, donor2	11332-117E9	27.79	1.26	0.90	0.36	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	21.38	0.31	1.15	0.10	0.52	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	89.42	1.46	0.36	0.00	2.19	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	55.10	1.59	1.25	0.49	0.69	0.62
Renal Epithelial Cells, donor1	11517-119H5	73.55	1.01	1.01	1.01	2.54	2.54
Renal Epithelial Cells, donor2	11597-120H4	51.22	2.85	2.13	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	41.60	0.85	1.27	0.11	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	31.32	10.21	0.00	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	25.74	13.21	0.67	0.13	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	23.53	3.33	0.67	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	29.94	7.99	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	55.90	3.08	2.42	0.22	1.10	0.66
Renal Mesangial Cells, donor2	11598-120H5	42.63	1.88	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	55.76	3.33	0.83	0.00	0.55	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	95.83	1.34	2.15	0.54	1.34	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	83.50	2.11	1.69	0.84	0.84	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	42.23	2.31	0.39	0.00	0.77	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.08	0.52	1.04	0.52	1.81	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.00	0.85	1.71	0.00	1.14	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	4.12	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	17.06	0.50	0.75	0.00	1.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	35.95	0.00	2.67	0.53	0.80	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	0.00	0.00	1.79	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.81	0.55	2.20	2.20	3.30	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.66	1.16	1.74	0.58	3.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.41	1.04	0.65	0.26	1.82	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.06	0.79	0.89	0.60	0.99	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.86	1.78	0.45	0.67	3.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	14.76	0.37	0.00	0.87	1.36	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.75	0.47	0.82	0.70	2.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	19.18	1.62	1.16	0.69	1.85	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.39	1.10	0.55	0.82	1.51	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.64	0.61	0.30	0.30	1.36	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.79	0.18	0.54	0.90	2.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	18.65	0.72	0.86	0.43	2.15	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	21.36	1.07	0.43	0.64	1.50	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.36	1.33	1.11	0.22	2.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.87	0.57	0.00	0.57	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	16.40	1.02	0.47	0.65	1.02	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.73	0.56	0.38	0.38	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.65	1.19	0.53	0.53	1.73	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.23	0.88	0.88	0.68	1.36	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	18.90	1.34	0.76	0.38	1.53	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.05	1.07	0.43	0.43	1.82	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	18.22	1.12	0.28	0.56	1.68	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	16.92	1.20	0.68	0.85	1.37	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	16.05	0.36	1.64	0.55	0.91	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.15	0.98	0.61	0.86	1.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.28	0.94	0.81	0.54	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	16.75	0.94	0.24	0.71	2.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	19.64	0.99	0.40	0.40	1.19	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.32	1.40	0.47	0.00	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	13.06	0.21	0.62	0.21	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	18.36	1.33	0.88	0.22	1.55	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.76	1.04	0.42	0.21	1.46	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.15	0.27	0.94	0.67	1.35	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.96	1.02	1.02	0.85	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	19.09	0.77	2.31	0.00	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.44	1.03	1.72	0.34	1.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.24	0.69	1.37	0.69	0.96	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.58	0.82	1.31	0.49	2.46	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.90	1.19	0.68	1.02	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.86	2.52	1.48	0.59	3.26	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.46	0.27	0.00	0.27	2.93	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.91	0.97	0.83	0.69	1.38	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.29	1.43	1.19	0.24	2.14	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	21.36	1.21	1.41	0.40	1.61	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.83	0.75	0.47	0.85	1.51	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.80	0.35	0.70	1.05	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.04	0.60	1.21	1.51	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.34	0.86	2.08	0.49	1.71	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	24.89	0.73	1.60	0.87	2.77	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.95	2.43	1.22	1.22	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.78	1.21	1.81	0.30	2.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.29	0.90	0.68	0.90	3.17	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.35	1.80	0.90	0.30	1.50	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	38.49	0.83	0.24	1.77	3.42	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	28.39	0.43	1.28	0.85	1.92	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	0.60	1.20	0.60	1.80	1.20
Schwann Cells, donor1	11498-119F4	35.73	3.39	0.38	0.19	0.19	0.56
Schwann Cells, donor2	11578-120F3	20.41	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	23.00	2.63	0.44	0.00	0.66	0.22
Sebocyte, donor1	11220-116B5	49.85	0.00	0.00	1.64	1.64	0.55
Sebocyte, donor2	11301-117B5	34.93	0.00	0.92	0.00	0.00	0.92
Sebocyte, donor3	11378-118B1	54.62	0.21	0.41	0.41	0.82	0.21
Sertoli Cells, donor1	11255-116F4	29.82	1.66	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	2.82	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.84	2.29	0.18	0.70	0.97	0.18
Skeletal Muscle Cells, donor2	11358-117H8	23.85	2.89	5.78	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	22.57	0.84	0.00	1.67	0.00	2.51
Skeletal Muscle Cells, donor4	11451-119A2	44.77	2.83	0.63	0.31	1.10	1.10
Skeletal Muscle Cells, donor5	11455-119A6	42.07	2.53	0.89	0.00	0.59	1.04
Skeletal Muscle Cells, donor6	11459-119B1	30.16	2.46	0.31	0.31	1.39	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	57.71	3.15	0.50	0.25	1.13	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.67	3.71	0.71	0.14	0.29	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	27.28	3.37	0.40	0.60	1.09	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.10	1.60	2.02	0.34	1.01	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	34.74	2.90	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	40.32	4.27	0.83	0.55	0.14	0.69
Skin - palm, donor1	10286-104F7	16.12	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.21	0.86	1.01	0.14	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	18.81	0.82	1.64	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.71	0.52	0.65	0.00	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	61.86	0.14	2.09	1.11	1.81	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	26.72	0.28	0.28	0.14	0.42	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.66	0.00	0.85	0.00	1.27	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	57.26	0.15	1.72	0.45	0.75	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.16	0.93	0.31	0.31	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	48.69	0.00	0.44	0.22	0.22	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	43.50	0.00	0.59	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.89	3.09	1.33	0.66	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.23	0.39	0.79	0.00	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	39.40	1.55	0.00	0.77	1.55	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	20.02	4.00	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.01	1.20	0.27	0.40	1.06	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	29.26	2.44	1.99	0.00	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	25.99	0.90	0.51	0.38	0.51	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.00	2.60	0.33	0.00	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	37.21	1.48	1.48	0.59	0.89	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	41.71	1.85	1.28	0.00	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	41.97	2.77	0.16	0.16	0.49	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.74	0.91	0.00	0.00	0.91	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.82	1.26	1.52	0.25	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.50	4.29	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	37.02	1.77	0.44	0.29	0.29	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	37.67	1.72	0.00	0.22	1.29	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.80	3.25	0.63	0.31	0.52	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	36.50	0.46	0.93	0.46	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	4.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	27.20	0.30	0.00	0.00	0.90	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	61.45	5.46	0.34	0.34	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	33.53	1.33	0.79	0.16	0.71	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	22.34	0.20	0.70	0.20	0.81	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	36.86	3.19	0.68	0.23	0.46	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.38	1.81	1.21	0.60	0.60	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.08	1.32	0.26	0.00	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.23	1.07	0.93	0.80	0.53	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	33.43	1.00	0.50	0.25	0.63	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	1.01	0.76	0.00	1.01	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	36.03	1.21	1.36	0.15	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.76	1.50	0.00	0.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	7.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	38.14	0.47	0.93	0.47	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	36.86	1.01	0.00	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	35.41	2.51	0.63	0.31	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	47.20	0.29	1.18	0.59	0.29	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.16	1.08	1.00	0.00	0.33	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	35.04	2.34	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.06	1.15	0.58	0.14	0.72	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.44	2.29	1.02	0.00	0.00	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.90	2.26	0.19	0.19	1.13	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	42.76	2.93	1.12	0.42	0.98	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	35.69	2.18	0.59	0.34	0.42	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	84.28	0.95	0.95	0.48	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.44	0.98	0.73	0.24	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.28	0.44	0.22	0.00	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.36	0.88	0.59	0.00	1.46	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.41	0.58	0.97	0.00	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	33.59	1.06	0.00	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	0.37	0.00	0.37	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	41.32	0.00	0.00	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.96	0.28	0.28	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.03	0.39	0.79	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	31.74	0.25	0.51	0.25	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	19.17	3.59	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	33.02	0.84	1.25	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	23.38	0.92	1.83	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	19.36	0.34	1.18	0.17	0.67	0.17
Synoviocyte, donor2	11368-117I9	24.31	1.51	2.35	0.67	0.50	0.17
Synoviocyte, donor3	11440-118H9	24.35	0.67	3.13	0.00	0.22	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	48.24	3.22	0.36	0.71	2.14	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	87.21	1.98	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	61.13	5.56	0.23	0.23	0.93	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	63.15	0.79	0.86	0.57	0.65	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	43.30	0.00	0.39	0.39	1.16	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	57.84	0.00	0.00	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	36.54	0.12	1.97	0.37	0.62	0.62
Urethra, donor2	10319-105A4	17.98	0.00	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	65.35	0.80	0.27	0.53	0.00	0.27
Urothelial Cells, donor2	11600-120H7	78.51	0.80	0.40	0.00	0.80	0.80
Urothelial Cells, donor3	11681-122H7	66.70	0.92	0.46	0.46	0.46	0.46
Urothelial cells, donor0	11216-116B1	71.55	0.45	1.11	1.34	0.89	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	72.96	1.78	0.89	0.89	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	74.34	0.00	1.43	0.00	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	0.68	0.68	0.00	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.89	0.34	1.03	0.69	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.63	1.16	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	52.06	2.08	0.00	1.04	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	66.08	0.92	1.84	0.00	1.84	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.04	0.91	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	15.05	1.23	0.62	0.37	0.74	0.37
Wilms' tumor cell line:HFWT	10597-108E3	54.56	0.88	0.88	0.88	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.47	0.28	0.56	0.28	0.84	0.00
achilles tendon, donor2	10292-104G4	16.53	2.07	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	45.38	7.14	0.51	0.25	1.53	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	49.45	4.88	0.00	1.39	2.09	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.35	0.95	0.00	0.59	1.19	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	36.19	0.00	0.00	0.54	2.99	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	32.32	19.39	0.56	0.28	1.97	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	60.70	4.86	2.54	0.63	1.48	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	41.92	8.71	1.91	0.27	0.82	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.78	0.00	0.88	0.00	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	66.56	14.70	2.04	0.82	5.72	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	17.86	1.16	0.00	0.39	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	16.01	0.92	0.18	0.92	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	11.70	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	43.69	4.65	1.63	0.70	2.56	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.85	0.52	1.04	0.00	2.85	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.16	0.88	0.58	0.29	1.17	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.35	0.93	1.39	1.39	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	56.75	2.06	1.65	0.82	3.70	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.63	0.31	0.92	0.61	0.31	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	33.71	1.71	1.71	1.28	3.41	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	35.49	1.82	1.82	1.21	1.82	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	42.60	0.48	1.68	2.41	3.85	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	45.66	5.57	1.34	0.89	3.34	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	34.02	0.67	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	0.00	3.72	0.00	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	66.67	12.43	7.53	0.75	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.00	10.03	0.87	0.44	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	7.50	0.00	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	134.47	0.24	3.53	2.83	3.06	1.65
adipose tissue, adult, pool1	10010-101C1	18.30	0.62	1.24	0.00	0.31	0.47
adipose, donor1	10184-103D4	19.35	6.45	0.59	0.59	0.59	0.59
adipose, donor2	10185-103D5	15.41	0.41	0.00	0.41	0.41	0.81
adipose, donor3	10186-103D6	17.70	2.18	0.00	0.54	0.82	0.54
adipose, donor4	10187-103D7	26.87	5.20	0.87	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	101.32	1.89	0.32	0.63	0.16	3.95
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	0.00	0.00	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	92.72	3.20	0.67	1.47	2.13	1.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	30.01	1.79	2.50	0.00	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	36.40	0.00	4.64	0.93	0.70	0.70
amniotic membrane cells, donor2	12236-129G4	35.50	0.00	1.35	1.01	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	23.27	0.00	5.89	0.59	0.00	0.59
amygdala - adult, donor10196	10167-103B5	7.11	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	9.94	0.20	1.62	0.00	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	9.68	0.65	1.61	0.00	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	20.75	1.66	0.51	0.25	0.38	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	105.02	12.80	2.65	2.21	3.97	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	20.04	1.00	0.00	1.00	0.67	0.33
aorta, adult, pool1	10052-101G7	16.87	0.39	2.35	0.20	0.20	0.78
appendix, adult	10189-103D9	37.26	0.39	1.16	0.78	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	57.78	1.38	0.34	0.34	2.06	1.38
artery, adult	10190-103E1	2.72	0.00	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	66.06	2.75	0.29	1.01	3.62	0.14
b cell line:RPMI1788	10427-106D4	46.25	7.14	0.15	0.15	0.15	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	30.80	0.00	0.83	0.28	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	68.37	0.20	1.09	0.69	1.79	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	97.41	0.33	4.35	2.18	3.51	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	0.56	5.03	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	19.66	0.22	1.85	0.11	0.33	0.33
blood, adult, pool1	10053-101G8	28.79	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	0.86	0.86	0.00	3.43	0.86
bone marrow, adult	10192-103E3	28.34	1.35	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	6.15	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	7.13	0.22	0.11	0.00	0.22	0.67
brain, fetal, pool1	10085-102B4	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	55.83	0.33	0.99	1.65	2.64	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	200.84	0.25	1.75	3.12	6.87	0.87
breast, adult, donor1	10080-102A8	17.05	0.63	0.63	0.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	69.74	0.76	1.27	2.67	2.29	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.71	1.55	0.93	1.24	6.18	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	78.73	5.76	2.53	0.46	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	87.88	0.00	2.91	2.18	4.84	0.97
carcinoid cell line:NCI-H1770	10703-109H1	83.22	1.41	0.00	0.47	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	47.80	0.22	1.31	0.66	0.98	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	32.64	1.58	0.32	0.32	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	19.16	6.12	0.80	0.00	1.60	0.00
caudate nucleus - adult, donor10196	10177-103C6	10.36	0.00	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	9.20	0.00	1.34	0.00	0.17	0.50
caudate nucleus, adult, donor10258	10379-105H1	11.46	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	7.69	0.37	0.37	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	6.62	0.00	0.64	0.00	0.21	0.00
cerebellum, adult, pool1	10083-102B2	8.28	0.00	0.34	0.34	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	6.64	0.00	0.00	0.00	0.00	1.66
cerebral meninges, adult	10188-103D8	7.82	0.00	0.25	0.00	0.00	0.76
cerebrospinal fluid, donor2	10294-104G6	10.23	1.46	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	104.24	0.43	4.74	1.01	3.45	0.72
cervical cancer cell line:ME-180	10553-107I4	19.06	0.00	1.49	0.50	0.66	0.33
cervix, adult, pool1	10013-101C4	21.21	0.42	1.99	0.52	0.84	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.92	0.56	1.53	0.42	1.25	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	77.55	0.50	0.99	0.99	1.62	0.12
choriocarcinoma cell line:SCH	10785-110H2	123.71	0.49	1.36	1.72	1.97	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	56.21	0.00	0.71	0.00	1.66	0.95
chorionic membrane cells, donor1	12238-129G6	39.89	1.14	3.70	0.57	0.57	1.14
chorionic membrane cells, donor2	12239-129G7	46.63	0.30	0.89	0.20	0.99	0.70
chorionic membrane cells, donor3	12240-129G8	54.95	0.55	4.95	1.10	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	0.00	0.00	0.00	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	30.35	8.64	1.73	0.58	1.92	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	40.13	3.80	1.69	0.42	1.48	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	52.90	0.26	1.54	0.51	1.28	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.26	1.94	2.18	0.24	1.45	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	49.07	1.02	1.83	0.20	0.81	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	45.05	0.00	2.65	0.59	2.06	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	60.73	5.47	2.61	0.78	2.09	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	69.49	3.43	0.69	0.23	2.29	0.46
clear cell carcinoma cell line:TEN	10636-108I6	70.96	0.35	1.56	1.04	3.47	0.69
colon carcinoma cell line:CACO-2	10513-107D9	46.86	1.83	0.18	0.92	2.38	0.18
colon carcinoma cell line:COLO-320	10420-106C6	46.37	3.80	0.38	0.76	1.90	0.38
colon, adult, donor1	10082-102B1	53.55	1.19	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	35.84	0.47	2.23	0.59	0.47	0.00
colon, fetal, donor1	10070-101I7	33.99	0.00	0.62	0.00	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	36.67	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	47.17	26.35	1.70	0.85	5.10	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	46.64	34.26	2.72	0.60	1.96	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	41.32	31.87	2.54	0.42	1.83	0.28
corpus callosum, adult, pool1	10042-101F6	13.49	0.00	0.44	0.33	0.33	0.66
cruciate ligament, donor2	10295-104G7	13.78	0.00	1.62	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	0.80	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	6.24	0.00	0.24	0.00	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	29.62	5.51	0.00	0.46	2.30	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	87.70	0.51	0.77	1.03	2.56	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	64.03	2.89	2.89	0.96	0.48	0.00
ductus deferens, adult	10196-103E7	54.82	0.00	3.49	0.00	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	0.00	4.32	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	45.61	0.00	2.94	2.21	2.21	0.74
dura mater, adult, donor1	10041-101F5	28.66	2.15	0.74	0.33	0.41	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.09	3.33	1.55	0.67	2.66	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.05	0.72	0.43	1.43	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	25.28	1.85	0.00	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	42.68	0.91	0.00	0.00	0.30	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	40.14	0.62	0.00	0.62	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	43.34	0.00	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	164.25	2.68	2.68	3.02	2.01	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	46.76	0.54	0.36	0.18	1.63	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	113.69	0.64	1.13	0.32	2.41	1.29
epidermoid carcinoma cell line:A431	10426-106D3	48.24	0.11	1.56	0.44	1.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	34.32	0.77	1.43	0.33	1.87	0.00
epididymis, adult	10197-103E8	43.96	0.63	11.51	0.21	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.92	2.13	0.53	0.35	0.35	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.64	7.47	3.93	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	25.55	0.66	2.49	0.66	0.79	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.03	0.49	2.36	0.69	1.38	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.31	0.34	2.35	0.45	1.23	0.34
esophagus, adult, pool1	10015-101C6	33.13	0.32	1.81	0.42	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	70.26	1.63	1.50	1.13	0.50	0.63
eye - muscle inferior rectus, donor1	10272-104E2	9.66	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	10.32	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	23.14	0.25	1.53	0.25	0.51	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	30.65	2.44	0.64	0.26	0.90	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	48.91	4.99	0.71	0.00	1.42	1.19
frontal lobe, adult, pool1	10040-101F4	9.19	0.09	0.19	0.00	0.19	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	90.37	0.00	5.40	1.50	4.80	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	117.95	4.39	2.10	1.28	4.30	0.91
gall bladder, adult	10198-103E9	37.66	0.48	2.17	0.24	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	41.87	0.54	0.00	0.54	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	45.94	1.12	0.37	0.37	0.37	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	43.93	1.06	2.32	0.21	1.69	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	44.49	0.19	0.39	0.39	2.90	0.97
gastric cancer cell line:AZ521	10549-107H9	58.20	5.08	0.16	0.49	2.13	0.82
gastric cancer cell line:GSS	10560-108A2	43.93	0.92	0.00	0.92	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.29	1.37	0.46	1.14	1.37	0.69
giant cell carcinoma cell line:LU65	10487-107B1	23.18	0.00	0.69	0.23	1.61	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	49.13	2.24	1.26	0.56	0.84	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.36	0.00	2.74	0.25	2.74	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.55	0.32	1.27	0.21	1.27	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	26.96	0.28	0.70	0.28	0.70	0.70
glioblastoma cell line:T98G	10485-107A8	32.56	3.75	1.10	0.77	1.43	0.77
glioma cell line:GI-1	10413-106B8	42.76	1.17	1.17	1.17	1.17	0.29
globus pallidus - adult, donor10196	10175-103C4	10.93	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	15.38	0.24	2.44	0.00	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	5.48	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	5.86	0.00	0.53	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	14.68	4.89	2.45	0.00	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	5.23	10.45	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.92	1.92	0.00	0.32	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	35.35	5.51	0.46	0.00	2.30	0.00
hIPS +CCl2, biol_rep2	14384-156C1	33.38	8.23	0.00	0.00	2.29	0.00
hIPS +CCl2, biol_rep3	14385-156C2	50.24	6.44	0.00	0.64	1.93	0.00
hIPS, biol_rep1	14380-156B6	27.31	12.94	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	39.09	6.17	0.69	0.00	3.43	0.00
hIPS, biol_rep3	14382-156B8	15.45	1.10	0.00	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	37.35	10.34	0.29	0.29	0.29	0.86
heart - mitral valve, adult	10205-103F7	12.26	0.00	1.20	0.00	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	10.98	0.00	0.78	0.00	0.26	0.78
heart - tricuspid valve, adult	10207-103F9	13.32	0.00	7.49	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	40.61	0.20	1.22	1.22	0.82	0.41
heart, adult, diseased, donor1	10051-101G6	10.22	0.00	0.43	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	10.12	0.00	1.84	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	14.89	1.13	1.03	0.31	1.13	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.82	0.31	1.54	0.00	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	0.00	0.00	0.00	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.33	2.10	0.99	0.33	0.99	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.66	1.09	0.36	0.24	0.97	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.02	1.52	1.21	0.40	0.81	0.20
hepatoma cell line:Li-7	10484-107A7	24.02	0.44	1.00	0.44	1.78	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	61.00	15.58	0.50	0.90	3.62	0.90
hippocampus - adult, donor10196	10169-103B7	9.46	0.00	0.95	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	10.82	0.00	1.84	0.41	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	6.47	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	10.22	0.00	1.76	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	46.39	11.60	0.61	0.00	7.32	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	42.81	5.11	0.00	0.39	1.37	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	46.97	5.84	0.25	0.51	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	34.96	3.95	0.00	0.56	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	40.54	6.46	0.26	0.26	0.77	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	46.31	3.80	0.00	0.00	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.68	3.50	0.00	0.88	1.46	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	14.65	1.08	0.00	0.22	0.43	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.85	2.50	0.00	0.00	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.13	1.66	0.24	0.47	1.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.27	1.29	0.16	0.48	0.80	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	2.02	0.67	0.67	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	40.06	3.44	0.00	0.63	1.41	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.76	5.90	0.00	0.98	0.98	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	11.35	0.00	0.87	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	30.93	3.44	0.19	0.00	0.76	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.09	3.05	0.00	0.44	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	31.48	10.99	0.00	0.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.94	1.51	0.00	0.00	0.00	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.46	0.91	0.45	0.00	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.72	1.88	0.00	0.94	0.31	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.47	2.12	0.33	0.49	0.98	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	17.42	2.03	0.00	0.00	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	16.74	2.09	0.00	0.00	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	46.37	6.84	0.37	0.18	2.03	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	50.21	8.84	0.00	0.57	1.43	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	61.66	8.17	0.00	0.00	2.04	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.65	3.52	0.00	0.35	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.56	5.38	0.00	0.00	0.32	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.87	4.84	0.30	0.30	0.91	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	22.24	3.10	0.52	0.00	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	32.54	0.66	0.00	1.33	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	19.50	1.28	0.51	0.00	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.45	2.81	0.26	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	2.27	0.76	0.00	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	24.53	2.69	0.34	0.34	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	45.16	7.97	0.00	0.48	2.66	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	49.02	10.25	0.45	0.89	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	45.85	4.39	0.00	0.00	3.41	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	23.84	3.97	0.00	0.61	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	32.53	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	34.42	5.96	0.00	0.00	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	19.70	1.09	0.55	0.55	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.18	3.26	0.36	0.72	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.39	3.20	0.00	0.00	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	3.58	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.08	2.71	0.14	0.41	0.95	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.39	2.16	0.54	0.54	1.62	0.54
immature langerhans cells, donor1	11904-125F5	7.26	1.21	1.94	0.00	0.00	0.48
immature langerhans cells, donor2	11905-125F6	13.47	0.79	3.17	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	11.36	0.09	0.19	0.19	0.28	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	52.35	0.00	1.63	1.63	0.33	0.98
kidney, adult, pool1	10017-101C8	41.15	0.20	4.11	0.50	1.40	0.50
kidney, fetal, pool1	10045-101F9	36.50	1.27	1.34	0.64	1.56	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	52.41	3.83	1.14	0.57	1.56	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	73.41	0.97	0.55	0.41	0.97	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.01	0.73	0.00	1.28	2.75	0.55
left atrium, adult, donor1	10079-102A7	13.62	0.00	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	11.63	0.00	2.02	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	42.14	4.38	1.09	0.00	2.19	1.37
leiomyoma cell line:10964C	10569-108B2	29.82	0.36	0.00	0.00	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	26.09	0.54	0.54	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	21.12	0.97	0.73	0.00	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	0.00	1.05	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	33.53	6.61	0.47	0.35	1.18	0.24
liposarcoma cell line:KMLS-1	10782-110G8	46.71	2.03	0.62	0.78	1.87	0.94
liposarcoma cell line:SW 872	10726-110A6	34.97	7.19	0.61	0.37	1.58	0.49
liver, adult, pool1	10018-101C9	43.92	0.65	5.67	0.16	1.78	0.16
liver, fetal, pool1	10086-102B5	25.40	4.70	0.94	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	8.31	0.00	0.58	0.15	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	14.21	0.00	0.74	0.37	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	13.54	0.00	0.00	0.56	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	7.15	1.26	2.10	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	69.06	0.55	2.91	0.14	2.21	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	84.11	0.00	1.38	0.00	2.76	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	104.93	2.11	1.85	0.92	1.58	0.92
lung, adult, pool1	10019-101D1	48.90	0.95	2.60	0.47	0.71	0.12
lung, fetal, donor1	10068-101I5	30.82	0.57	0.57	0.00	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	17.41	0.46	1.83	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	30.30	3.31	1.89	0.47	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	100.16	9.64	5.48	0.88	2.19	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	44.67	8.15	0.15	0.30	1.51	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	38.23	0.00	3.40	0.00	3.40	1.70
mature adipocyte, donor1	12231-129F8	13.32	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	15.56	1.04	1.66	0.83	0.42	0.21
mature adipocyte, donor3	12233-129G1	14.22	0.95	2.84	0.00	0.95	1.19
mature adipocyte, donor4	12234-129G2	20.79	0.26	1.84	0.79	2.11	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.28	0.00	0.48	0.95	1.43	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	8.64	0.00	1.84	0.00	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	7.94	0.00	0.00	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	8.53	0.85	1.28	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.44	0.17	0.51	0.00	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	11.25	0.00	0.64	0.21	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.90	0.36	1.44	0.36	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	12.33	0.65	1.30	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	11.30	0.00	1.86	0.46	0.31	0.62
medulla oblongata, adult, pool1	10038-101F2	10.29	0.08	0.24	0.24	0.33	0.49
medulla oblongata, newborn, donor10223	10361-105F1	8.33	0.00	2.43	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	40.30	3.99	0.66	0.89	1.77	0.22
medulloblastoma cell line:ONS-76	10759-110E3	42.92	0.86	0.61	0.61	1.10	0.61
melanoma cell line:COLO 679	10514-107E1	39.39	0.72	1.15	0.72	1.29	0.43
melanoma cell line:G-361	10465-106H6	45.06	0.54	0.27	0.00	1.36	1.09
meningioma cell line:HKBMM	10691-109F7	36.18	1.45	1.63	0.18	0.72	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	20.27	0.00	0.00	0.00	4.41	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	35.00	0.78	0.00	0.26	1.56	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	37.13	1.84	1.38	0.77	0.77	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.90	2.73	1.64	0.00	0.55	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	44.72	0.83	0.83	0.41	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.15	0.42	0.56	0.14	0.84	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	37.36	0.96	0.39	0.00	0.39	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.70	0.00	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	66.08	0.34	1.72	0.34	1.20	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.34	0.58	1.27	0.23	0.35	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.96	2.79	0.53	0.40	0.93	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	29.17	1.22	0.27	0.27	0.41	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	27.88	1.85	0.57	0.14	0.28	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	61.26	2.96	2.31	0.33	0.66	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	30.44	1.11	0.42	0.69	0.28	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	53.41	1.40	3.14	0.00	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.91	0.20	1.02	0.82	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.99	1.44	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	43.04	0.93	1.14	0.31	0.72	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.95	0.46	2.05	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	32.31	0.42	0.42	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.20	1.34	0.15	0.00	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	54.01	4.46	1.75	0.26	0.70	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.86	1.10	1.10	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	27.76	0.00	0.57	0.00	1.14	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	1.26	0.42	0.00	0.84	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	33.79	1.37	0.46	1.37	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	33.76	0.51	0.00	0.26	1.02	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.08	0.79	0.52	0.26	1.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	34.20	0.92	0.62	0.92	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.60	0.94	0.71	0.00	1.41	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	35.88	0.68	0.34	0.34	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.73	1.57	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	29.19	0.46	0.93	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.65	2.31	0.29	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	36.37	1.34	0.67	0.22	0.45	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	41.10	0.96	0.24	0.00	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	36.67	0.00	0.73	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.23	2.69	0.34	0.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	42.17	1.23	0.82	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	28.78	0.43	0.86	0.00	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	2.73	0.00	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.10	0.65	1.62	0.00	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	46.91	1.07	0.00	0.00	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	32.71	0.82	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	40.04	1.17	1.17	0.00	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	38.75	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.17	2.96	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	2.44	0.00	1.22	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	0.63	0.63	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	27.94	1.38	1.38	0.34	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	3.44	3.44	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.26	0.41	0.81	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	0.79	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	1.18	0.59	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.26	0.94	0.94	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	29.57	1.18	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.29	0.00	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	57.89	0.49	0.00	0.99	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	39.25	1.12	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	62.33	1.91	0.64	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	116.06	0.40	0.00	0.40	2.42	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	115.57	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	108.97	1.27	1.27	0.00	3.80	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	58.87	0.00	3.64	0.61	3.03	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	76.60	0.00	3.29	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	33.73	0.20	1.19	0.20	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.15	0.32	2.27	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	0.00	2.04	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	15.47	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	65.91	1.65	1.18	0.47	0.47	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	56.53	2.55	5.56	1.16	2.09	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	64.42	3.60	1.75	0.92	2.16	0.62
mesothelioma cell line:Mero-25	10850-111F4	34.50	3.40	0.91	0.45	1.36	0.00
mesothelioma cell line:Mero-41	10851-111F5	19.80	1.47	2.69	0.00	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	43.40	1.77	1.33	0.00	1.11	0.89
mesothelioma cell line:Mero-82	10853-111F7	23.39	1.84	1.05	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	21.62	1.36	0.51	0.17	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	42.97	2.02	1.26	0.25	1.01	0.51
mesothelioma cell line:Mero-95	10856-111G1	52.80	1.04	2.48	0.41	1.24	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	20.21	1.82	0.99	0.00	1.16	0.17
mesothelioma cell line:NCI-H226	10846-111E9	21.54	1.63	2.17	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	58.08	3.59	3.42	0.51	1.71	0.51
mesothelioma cell line:NCI-H28	10845-111E8	10.94	0.51	0.76	0.00	0.76	0.00
mesothelioma cell line:No36	10857-111G2	21.86	0.00	0.33	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	39.29	2.17	0.54	0.00	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	34.55	3.45	1.15	0.38	2.69	0.19
migratory langerhans cells, donor2	11902-125F3	34.68	1.10	0.98	0.24	0.98	0.98
migratory langerhans cells, donor3	11903-125F4	39.13	1.62	0.54	0.00	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	43.75	0.33	0.33	1.31	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.21	0.42	0.85	0.42	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	59.66	0.00	2.30	0.46	1.15	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.64	6.47	0.57	0.19	0.57	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	77.43	1.48	0.55	3.14	5.54	0.92
myeloma cell line:PCM6	10474-106I6	119.79	0.59	1.38	2.37	3.76	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	40.08	0.00	1.01	0.00	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	27.85	0.39	0.39	0.39	1.57	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	134.71	0.11	2.23	1.56	0.89	1.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	133.26	0.37	2.87	0.81	1.25	0.96
nasal epithelial cells, donor2	12227-129F4	78.93	0.00	1.10	1.10	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	12.42	1.84	0.00	0.23	2.07	0.23
neuroblastoma cell line:NB-1	10539-107G8	84.56	8.61	1.50	1.12	4.30	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	38.17	1.90	0.21	1.48	2.95	0.63
neuroblastoma cell line:NH-12	10555-107I6	18.26	3.91	0.00	0.19	0.93	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	32.03	1.66	0.00	0.47	1.42	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.27	0.32	0.48	0.48	0.95	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	44.68	1.21	0.00	1.41	2.42	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	0.64	0.00	0.00	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	30.61	1.33	1.06	0.00	0.80	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	37.21	2.20	0.51	1.01	1.18	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	112.07	2.40	0.00	1.60	4.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.21	1.92	1.92	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.17	1.84	1.31	0.53	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	9.94	0.09	0.19	0.09	0.19	0.28
occipital cortex - adult, donor10196	10172-103C1	14.42	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	17.98	0.00	1.61	0.00	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	11.28	0.36	1.82	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	7.08	0.00	0.26	0.26	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	9.87	0.43	0.00	0.00	0.86	0.86
occipital pole, adult, pool1	10036-101E9	8.12	0.24	0.00	0.00	0.08	0.32
olfactory region, adult	10195-103E6	7.83	0.19	0.19	0.19	0.00	0.19
optic nerve, donor1	10277-104E7	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	52.63	0.11	3.65	0.91	1.71	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	39.16	0.82	0.14	0.55	0.82	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	31.16	0.34	0.17	0.17	1.35	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.90	0.12	0.69	0.58	1.04	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	7.94	0.29	0.29	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	10.28	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	33.08	9.12	0.85	1.91	4.45	0.42
ovary, adult, pool1	10020-101D2	20.18	0.70	2.62	0.61	0.96	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	44.00	2.02	1.47	0.37	0.37	1.10
pancreas, adult, donor1	10049-101G4	85.60	0.94	8.47	0.94	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	35.78	0.28	0.00	0.84	2.52	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	17.55	1.36	1.87	0.34	1.36	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	52.32	0.17	0.99	0.66	1.32	1.16
paracentral gyrus, adult, pool1	10035-101E8	7.87	0.00	0.27	0.00	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	8.07	0.00	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	8.46	0.00	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	10.55	0.00	0.29	0.00	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	8.46	0.09	0.26	0.00	0.26	0.26
parietal lobe, fetal, donor1	10072-101I9	7.76	0.97	0.97	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.23	0.37	1.50	0.00	1.12	0.00
parotid gland, adult	10199-103F1	48.72	0.00	1.23	0.62	1.85	1.23
penis, adult	10200-103F2	17.19	0.54	1.07	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.76	0.00	0.19	0.37	0.19	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	89.46	0.29	1.02	1.17	1.75	1.17
pineal gland - adult, donor10196	10179-103C8	4.52	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	16.58	0.00	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	6.90	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	21.25	0.00	1.01	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	29.19	0.52	2.08	0.52	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	23.83	0.00	0.00	0.00	0.85	0.85
placenta, adult, pool1	10021-101D3	30.96	0.65	1.94	0.43	0.97	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	50.45	6.89	0.13	0.53	1.32	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	20.54	0.16	0.78	0.47	0.62	0.31
pons, adult, pool1	10033-101E6	10.93	0.17	0.17	0.00	0.26	0.17
postcentral gyrus, adult, pool1	10032-101E5	7.58	0.00	0.17	0.00	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	0.00	2.09	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	110.56	4.66	1.75	0.87	2.62	1.31
prostate cancer cell line:PC-3	10439-106E7	122.51	2.36	2.72	1.63	3.09	0.36
prostate, adult, pool1	10022-101D4	19.59	0.45	0.82	0.09	0.54	0.27
putamen, adult, donor10196	10176-103C5	8.73	0.24	0.24	0.00	0.24	0.24
putamen, adult, donor10252	10152-102I8	17.65	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	5.56	0.00	0.24	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	3.75	0.00	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	82.63	0.58	2.33	1.16	2.62	0.87
rectum, fetal, donor1	10067-101I4	25.04	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.46	1.06	1.27	0.21	1.06	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	45.15	0.83	0.83	0.00	0.41	0.83
retina, adult, pool1	10030-101E3	24.05	0.99	0.99	0.60	0.99	0.60
retinoblastoma cell line:Y79	10475-106I7	13.77	0.00	0.00	0.26	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.31	5.53	1.23	0.49	0.86	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	35.43	3.37	0.00	0.28	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	2.27	1.52	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	23.47	0.16	0.81	0.16	0.32	0.00
salivary acinar cells, donor2	11772-123I8	21.89	0.00	1.38	0.14	0.83	0.14
salivary acinar cells, donor3	11773-123I9	23.17	0.00	3.31	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	88.65	0.00	1.14	0.57	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.11	1.26	1.01	0.51	0.84	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.38	1.41	1.41	0.82	0.94	0.35
seminal vesicle, adult	10201-103F3	30.69	0.00	2.12	0.53	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	78.71	0.73	9.23	0.49	2.43	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	27.18	1.51	0.75	0.25	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	26.09	0.00	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	123.98	0.54	5.51	0.81	0.67	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	30.84	0.11	0.99	0.88	1.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	52.77	0.00	2.06	1.16	1.42	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	7.20	0.24	0.72	0.00	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	7.04	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	19.57	1.89	0.63	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.34	0.00	0.00	1.67	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.29	1.58	0.00	0.95	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	145.72	5.78	0.00	1.16	2.89	5.01
small cell lung carcinoma cell line:LK-2	10541-107H1	29.17	0.00	0.00	0.33	1.15	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	38.93	1.13	0.00	0.48	0.80	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	43.15	1.96	0.87	0.22	2.40	0.87
small intestine, adult, pool1	10024-101D6	64.02	0.12	3.22	0.84	1.55	0.48
small intestine, fetal, donor1	10064-101I1	46.68	1.47	2.70	1.23	1.72	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	50.78	0.00	1.54	0.51	4.10	0.00
smooth muscle, adult, pool1	10048-101G3	13.70	1.03	0.52	0.00	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	139.37	0.00	1.34	1.88	3.75	1.61
spinal cord - adult, donor10196	10181-103D1	13.08	0.00	2.06	0.23	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	14.98	0.00	0.39	0.00	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	11.76	0.00	1.38	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	22.56	0.61	1.83	0.00	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	10.56	0.92	2.76	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.40	0.30	0.90	0.45	0.90	0.45
spleen, adult, pool1	10025-101D7	43.83	1.87	3.08	0.33	0.55	0.44
spleen, fetal, pool1	10044-101F8	39.09	2.94	1.43	0.48	0.87	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	37.06	6.73	0.52	0.41	1.04	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	110.89	0.57	2.85	2.28	0.95	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	75.83	0.35	0.70	0.35	2.10	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	86.79	1.17	1.95	1.17	2.74	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	36.36	0.11	1.69	0.90	2.81	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	112.25	0.42	0.00	0.42	3.39	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	40.61	1.27	1.27	1.69	1.69	0.42
stomach, fetal, donor1	10062-101H8	64.08	1.07	1.07	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	34.18	0.00	2.28	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	10.39	0.21	1.87	0.00	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	8.28	0.00	0.52	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	7.07	0.71	1.41	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.45	0.92	0.00	0.23	1.60	0.92
temporal lobe, adult, pool1	10031-101E4	8.65	0.08	0.17	0.00	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	15.67	0.00	0.00	0.00	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.43	1.76	0.00	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	33.86	0.70	1.40	0.00	1.05	0.00
tenocyte, donor2	11765-123I1	27.09	0.00	1.53	0.38	1.14	0.76
tenocyte, donor3	11768-123I4	33.36	0.00	1.11	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	56.60	6.97	0.34	0.85	1.53	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	75.84	11.56	1.08	0.92	2.62	1.08
teratocarcinoma cell line:PA-1	10807-111A6	18.91	1.70	0.00	0.00	0.77	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	36.94	4.19	0.13	0.76	0.76	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	1.13	0.00	0.00	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	18.98	1.85	0.22	0.33	0.76	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.22	1.30	0.65	0.33	2.28	0.65
testis, adult, pool1	10026-101D8	22.98	0.43	2.04	0.97	2.15	0.97
testis, adult, pool2	10096-102C6	23.91	0.00	1.80	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	11.04	1.10	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	13.75	0.00	2.34	0.31	0.31	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.25	0.16	0.49	0.16	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	7.48	0.00	0.58	0.00	0.00	0.00
throat, adult	10209-103G2	22.72	0.00	0.75	0.50	0.25	0.75
throat, fetal, donor1	10061-101H7	25.29	1.52	0.91	0.61	0.30	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	57.83	3.38	0.20	0.79	1.79	0.20
thymus, adult, pool1	10027-101D9	23.66	0.40	0.40	0.20	0.89	1.29
thymus, fetal, pool1	10043-101F7	34.18	0.73	0.73	0.31	0.83	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	39.76	3.59	1.86	1.06	1.60	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	44.00	2.37	1.26	0.70	1.40	0.70
thyroid, adult, pool1	10028-101E1	43.95	0.28	5.13	0.93	1.31	0.56
thyroid, fetal, donor1	10060-101H6	37.44	0.26	1.58	1.05	0.26	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	25.12	0.00	2.09	0.00	0.23	0.00
tongue, fetal, donor1	10059-101H5	23.25	0.39	0.00	0.00	0.39	0.79
tonsil, adult, pool1	10047-101G2	54.60	1.60	1.10	0.40	1.00	0.90
trachea, adult, pool1	10029-101E2	46.22	0.57	5.40	0.41	0.90	0.33
trachea, fetal, donor1	10058-101H4	28.85	0.77	3.85	0.77	1.15	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.80	0.35	1.06	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	33.54	1.22	0.61	0.81	2.23	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	115.32	4.39	5.95	1.25	2.35	1.57
tridermal teratoma cell line:HGRT	10694-109G1	13.32	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.51	0.93	1.02	0.59	1.10	0.59
umbilical cord, fetal, donor1	10057-101H3	25.04	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	23.55	0.68	1.54	1.02	0.85	0.68
uterus, fetal, donor1	10055-101H1	23.55	1.54	0.00	0.51	0.51	2.05
vagina, adult	10204-103F6	10.99	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	27.84	0.88	1.32	0.00	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	44.86	9.35	0.00	0.00	0.27	1.34

Property "Nearest transcripts" (as page type) with input value "ENST00000490276.5:14 ENST00000303343.12:36 AF126023:36 BC009621:36 ENST00000368404.9:38 NM_001287586.2:38 NM_001287589.2:38 NM_001122837.2:38 NM_001287588.2:38 NM_001122839.2:38 NM_018845.4:38 NM_001287587.2:38 ENST00000650403.1:44 AF126024:44 ENST00000368405.7:45 BC012378:49 ENST00000488609.5:53 BC005943:54 LF206179:-55 MA441756:-55 ENST00000506037.1:83 BC010869:83 BC069245:83 HQ447165:93 KJ894297:93 KJ899222:93 CR457148:98 CU679421:98 LF352217:217 MA587794:217 LF352216:390 MA587793:390 ENST00000465546.5:-415 ENST00000475824.6:-417 NM_001287592.2:-433 NM_001287591.2:-433 NM_001287590.2:-433 ENST00000490770.5:-451 ENST00000484157.5:-464" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.